NovaBridge Biosciences
Asset & Liabilities Breakdown
Asset Breakdown FY2024
Total Assets: $212.7M
Liabilities Breakdown FY2024
Total Liabilities: $11.5M
Asset Breakdown
Total Assets: $212.7M
| Line Item | Value | % of Total |
|---|---|---|
| Cash & Equivalents | $68.3M | 32.1% |
| Accounts Receivable | $0 | 0.0% |
| Inventory | $0 | 0.0% |
| Property, Plant & Equipment | $201.0K | 0.1% |
| Goodwill | $0 | 0.0% |
| Intangible Assets | $0 | 0.0% |
| Other Assets | $144.2M | 67.8% |
Liabilities Breakdown
Total Liabilities: $11.5M
| Line Item | Value | % of Total |
|---|---|---|
| Accounts Payable | $7.5M | 65.4% |
| Long-Term Debt | $0 | 0.0% |
| Other Liabilities | $4.0M | 34.6% |